Table 2.
Chemoterapeutical drug | Cardiovascular manifestations |
---|---|
Anthracyclines | LVD, HF, myocarditis, arrhythmia |
5-fluorourcil | Ischemia, HF, pericarditis, cardiogenic shock |
Taxanes (paclitaxel), vinca alkaloids | Sinus bradicardia, ventricular tachycardia, atrioventricular block, HF, ischemia |
Cyclophosphamide | HF (neurohumoral activation), mitral regurgitation |
Trastuzumab | HF, LVD, arrhythmia |
Tamoxifen | Thromboembolism, cholesterol metabolism anomalies |
Bevacizumab | Hypertension, thromboembolism |
COX-2 specific inhibitors | Thromboembolism |
LVD: left ventricular dysfunction; HF: heart failure